Patrick Hargutt
Fondateur chez Stanley Capital Partners LLP
Postes actifs de Patrick Hargutt
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Stanley Capital Partners LLP
 Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital Partners LLP (Stanley Capital) is a private equity firm founded in 2019 by James Brooks, Patrick Hargutt and Simon W. Cottle. The firm is headquartered in London, United Kingdom. | Fondateur | 01/01/2020 | - |
| Private Equity Investor | 01/01/2020 | - | |
Noden Pharma DAC
 Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Noden Pharma DAC is a pharmaceutical company, which engages in the acquisition of prescription medicines across a range of therapeutic areas. It manufactures, markets, and sells Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor, for the treatment of hypertension. The company is headquartered in Dublin, Ireland. | Directeur/Membre du Conseil | 01/09/2020 | - |
Laboratoire X.O
 Laboratoire X.O Pharmaceuticals: MajorHealth Technology Laboratoire X.O SAS engages in the manufacture and development of pharmaceutical products and medications. The company was founded in 2015 and is headquartered in Paris, France. | Directeur/Membre du Conseil | 01/09/2022 | - |
| Stanley Lab, Inc. | Directeur/Membre du Conseil | 01/03/2021 | - |
Historique de carrière de Patrick Hargutt
Anciens postes connus de Patrick Hargutt
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| HEALTHCARE AI ACQUISITION CORP. | Directeur/Membre du Conseil | - | 12/06/2023 |
| Directeur Financier/CFO | - | 12/06/2023 | |
Monarch Alternative Capital (Private Equity)
 Monarch Alternative Capital (Private Equity) Investment ManagersFinance Monarch Alternative Capital(private equity) is a private equity firm founded in 2002. The firm is headquartered in New York with additional office in London. | Private Equity Investor | 01/01/2018 | 31/10/2019 |
Formation de Patrick Hargutt
| Technische Universität München | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Royaume-Uni | 2 |
| Irlande | 2 |
Opérationnelle
| Director/Board Member | 4 |
| Private Equity Investor | 2 |
| Founder | 1 |
Sectorielle
| Finance | 4 |
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HEALTHCARE AI ACQUISITION CORP. | Finance |
| Entreprise privées | 5 |
|---|---|
Stanley Capital Partners LLP
Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital Partners LLP (Stanley Capital) is a private equity firm founded in 2019 by James Brooks, Patrick Hargutt and Simon W. Cottle. The firm is headquartered in London, United Kingdom. | Finance |
Noden Pharma DAC
Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Noden Pharma DAC is a pharmaceutical company, which engages in the acquisition of prescription medicines across a range of therapeutic areas. It manufactures, markets, and sells Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor, for the treatment of hypertension. The company is headquartered in Dublin, Ireland. | Health Technology |
Laboratoire X.O
Laboratoire X.O Pharmaceuticals: MajorHealth Technology Laboratoire X.O SAS engages in the manufacture and development of pharmaceutical products and medications. The company was founded in 2015 and is headquartered in Paris, France. | Health Technology |
| Stanley Lab, Inc. | |
Monarch Alternative Capital (Private Equity)
Monarch Alternative Capital (Private Equity) Investment ManagersFinance Monarch Alternative Capital(private equity) is a private equity firm founded in 2002. The firm is headquartered in New York with additional office in London. | Finance |
- Bourse
- Insiders
- Patrick Hargutt
- Expérience
